10-Q Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001759655-22-000185`
Period End Date	20220930
Filing Date	20221110
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	prva-20220930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 75 Income Statement 76 Cash Flow Statement 68 Stockholders Equity 41

Balance Sheet 75 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$316.90M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$320.58M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	113.80M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.84M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	113.80M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$246.35M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$117.40M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.84M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.70M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$16.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$446.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$579.65M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.66M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.50M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$9.63M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$8.53M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$58.23M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.74M	USD	Point-in-time
Goodwill	`Goodwill`	$127.94M	USD	Point-in-time
Goodwill	`Goodwill`	$126.94M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$33.36M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$26.81M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.52M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.97M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$239.70M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$228.14M	USD	Point-in-time
Total assets	`Assets`	$807.79M	USD	Point-in-time
Total assets	`Assets`	$686.37M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$45.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$47.25M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$254.28M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$140.71M	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	-	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$3.00M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$2.89M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$304.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$190.46M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$31.69M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$9.19M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$11.04M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.00M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.00M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$12.19M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$45.73M	USD	Point-in-time
Total liabilities	`Liabilities`	$316.72M	USD	Point-in-time
Total liabilities	`Liabilities`	$236.19M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 113,796,678 and 107,837,741 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$1.14M	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 113,796,678 and 107,837,741 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$1.08M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$703.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$633.90M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-234.47M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-208.11M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$426.87M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$470.19M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$20.88M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$23.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$491.07M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$807.79M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$686.37M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$342.90M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$992.24M	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$251.52M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$690.89M	USD	3 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$265.17M	USD	1 Quarter
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$521.11M	USD	3 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$766.67M	USD	3 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$190.06M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$35.31M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$127.50M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$131.01M	USD	3 Qtrs
Cost of platform	`CostOfPlatform`	$43.84M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$4.59M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$14.57M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$18.95M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$5.09M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$101.44M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$33.91M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$216.56M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$32.22M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.15M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.44M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$466.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$888.98M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$347.47M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.01B	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$264.33M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.57M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-198.09M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-12.81M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-21.37M	USD	3 Qtrs
Interest (income) expense, net	`InterestIncomeExpenseNet`	$-610.00K	USD	3 Qtrs
Interest (income) expense, net	`InterestIncomeExpenseNet`	$285.00K	USD	1 Quarter
Interest (income) expense, net	`InterestIncomeExpenseNet`	$-885.00K	USD	3 Qtrs
Interest (income) expense, net	`InterestIncomeExpenseNet`	$-292.00K	USD	1 Quarter
Loss before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.29M	USD	1 Quarter
Loss before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-198.97M	USD	3 Qtrs
Loss before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-21.98M	USD	3 Qtrs
Loss before (benefit from) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.10M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-2.21M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-20.21M	USD	3 Qtrs
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$-4.84M	USD	1 Quarter
(Benefit from) provision for income taxes	`IncomeTaxExpenseBenefit`	$6.93M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.62M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-28.91M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$556.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-10.89M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.78M	USD	1 Quarter
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.51M	USD	3 Qtrs
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.07M	USD	1 Quarter
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.55M	USD	3 Qtrs
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$1.62M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-9.12M	USD	1 Quarter
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-26.36M	USD	3 Qtrs
Net income (loss) attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-176.25M	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.74	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.24	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.74	USD	3 Qtrs
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Net income (loss) per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.24	USD	3 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	109.46M	shares	3 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	105.90M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	101.58M	shares	3 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	111.59M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	105.90M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.58M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	109.46M	shares	3 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	124.85M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$5.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.91M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$556.00K	USD	1 Quarter
Net loss	`ProfitLoss`	$-10.89M	USD	1 Quarter
Net loss	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Depreciation	`Depreciation`	$869.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$927.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$800.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$2.51M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$482.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$687.00K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$120.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$228.46M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$58.18M	USD	3 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$-20.42M	USD	3 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$6.55M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-734.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$128.95M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.60M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.66M	USD	3 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$4.29M	USD	3 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$7.71M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$1.27M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$-176.00K	USD	3 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$113.57M	USD	3 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$38.19M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.75M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$10.03M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-5.26M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$67.38M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.04M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$89.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$396.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-89.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-396.00K	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$223.69M	USD	3 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	3 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	$12.69M	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$656.00K	USD	3 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$33.25M	USD	3 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$648.00K	USD	3 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$11.49M	USD	3 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$125.00K	USD	3 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	3 Qtrs
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$490.00K	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-21.63M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$210.50M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$277.48M	USD	3 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.68M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$362.11M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$316.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$362.11M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$316.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$680.00K	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$855.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$266.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$451.00K	USD	3 Qtrs

Stockholders Equity 41 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	113.80M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	107.84M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$491.07M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Issuance of common stock upon closing of initial public offering	`StockIssuedDuringPeriodValueNewIssues`	$210.99M	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.12M	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$799.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$615.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$33.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$8.57M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.83M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.47M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$101.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$24.88M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$25.80M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$202.56M	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$125.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$5.62M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-28.91M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$556.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-10.89M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-178.76M	USD	3 Qtrs
Ending balance (in shares)	`CommonStockSharesOutstanding`	113.80M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	107.84M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$405.00M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$491.07M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.